lancet-header
Preprints with The Lancet is part of SSRN´s First Look, a place where journals and other research experts identify content of interest prior to publication. These preprint papers are not peer-reviewed and are posted here as part of a 12-month trial. Authors have either opted in at submission to The Lancet family of journals to post their preprints on Preprints with The Lancet, or submitted directly via SSRN. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. These papers should not be used for clinical decision making or reporting of research to a lay audience without indicating that this is preliminary research that has not been peer-reviewed. For more information see the Comment published in The Lancet, or visit The Lancet´s FAQ page, and for any feedback please contact preprints@lancet.com

Tumor Induced PD-L1 on Neutrophils Suppress the Antitumor Immunity of NK Cells via PD-L1/PD-1 Axis

48 Pages Posted: 4 Jan 2019

See all articles by Rui Sun

Rui Sun

Huazhong University of Science and Technology (Formerly Tongi Medical University) - Department of Oncology

Ying-Ying Xiong

Huazhong University of Science and Technology (Formerly Tongi Medical University) - Department of Clinical Laboratory

Xiao-Dan Zheng

Huazhong University of Science and Technology (Formerly Tongi Medical University)

Chang Gao

Huazhong University of Science and Technology (Formerly Tongi Medical University) - Department of Oncology

Min Li

Huazhong University of Science and Technology (Formerly Tongi Medical University) - Department of Oncology

Bin Yan

Huazhong University of Science and Technology (Formerly Tongi Medical University)

Hong-Lin Jin

Huazhong University of Science and Technology (Formerly Tongi Medical University) - Cancer Center

Li Su

Huazhong University of Science and Technology (Formerly Tongi Medical University)

Jun Weng

Huazhong University of Science and Technology (Formerly Tongi Medical University)

Xiang-Lin Yuan

Huazhong University of Science and Technology (Formerly Tongi Medical University)

Dong-Xin Zhang

Huazhong University of Science and Technology (Formerly Tongi Medical University) - Department of Clinical Laboratory

Jueping Feng

Huazhong University of Science and Technology (Formerly Tongi Medical University) - Department of Oncology

More...

Abstract

In tumor-bearing state, the conversion of the system immune status makes the protumor function of neutrophils, and leading the suppression of NK cells cytotoxicity. The induced dysfunctional neutrophils could modulate the antitumor function of NK cells, but it is unclear whether and how the rebellious neutrophils modulate the NK cells anti-tumor function. Here we report that tumor-bearing neutrophils could impair NK cells cytotoxicity and the infiltration capability. Decreased CCR1 responsible for the weakened infiltration capability. Neutrophils could decrease the reactivity of NK activating receptor NKp46 and NKG2D. Induced PD-L1 expression (neutrophils) and PD-1 (NK cells) and the PD-L1/PD-1 axis were the main one mechanism of the suppression of NK cells immunity. Systemic increased G-CSF enhanced the expression of PD-L1, G-CSF/JAK2-STAT3 cell signaling pathway responsible to the upregulation of PD-L1. Tumor derived IL-18 enhances the PD-1 expression, block the IL-18 pathway by IL-18BP or knockdown the IL-18 expression by siRNA could both offset the IL-18 induced PD-1 expression. The neutrophils and NK cells crosstalk was cell-cell contact dependent, the affect of neutrophils on NK cells was disappeared when they were cultured in a separate system. These findings highlight the PD-L1/PD-1 signal on the immune suppression effect of neutrophils on NK cells. G-CSF and IL-18 producing might lead to a poor prognosis via different ways which cooperate to activate the immunosuppressive signal and weaken the antitumor affect of NK cells. Targeting G-CSF and IL-18 might be a potential approach to eliminate residual tumor cells in comprehensive strategy for tumor therapy.

Funding Statement: This work was supported by National Natural Science Foundation of China (No. 81502461, 81502265), Natural Science Foundation of Hubei province (NO. 2016CFB340), Key Project of Wuhan Municipal Health Planning Commission Key Project (NO. WX15A08). Huazhong University of Science and Technology "Double Top" Construction, Project of International Cooperation (NO. 540-5001540013).

Declaration of Interests: No potential conflicts of interest were disclosed.

Ethics Approval Statement: BALB/c mice, 6 wks old, were purchased from Center of Medical Experimental Animals of Hubei Province (Wuhan, China) for studies approved by the Animal Care and Use Committee of Tongji Medical College (Wuhan, China).

Keywords: PD-L1; neutrophils; NK cells; PD-1; IL-18

Suggested Citation

Sun, Rui and Xiong, Ying-Ying and Zheng, Xiao-Dan and Gao, Chang and Li, Min and Yan, Bin and Jin, Hong-Lin and Su, Li and Weng, Jun and Yuan, Xiang-Lin and Zhang, Dong-Xin and Feng, Jueping, Tumor Induced PD-L1 on Neutrophils Suppress the Antitumor Immunity of NK Cells via PD-L1/PD-1 Axis (January 1, 2019). Available at SSRN: https://ssrn.com/abstract=3309398

Rui Sun

Huazhong University of Science and Technology (Formerly Tongi Medical University) - Department of Oncology

No. 76 Jiefang Avenue
Wuhan, 430030
China

Ying-Ying Xiong

Huazhong University of Science and Technology (Formerly Tongi Medical University) - Department of Clinical Laboratory

No. 76 Jiefang Avenue
Wuhan, 430030
China

Xiao-Dan Zheng

Huazhong University of Science and Technology (Formerly Tongi Medical University)

1037 Luoyu Rd
Wuhan, Hubei 430074
China

Chang Gao

Huazhong University of Science and Technology (Formerly Tongi Medical University) - Department of Oncology

No. 76 Jiefang Avenue
Wuhan, 430030
China

Min Li

Huazhong University of Science and Technology (Formerly Tongi Medical University) - Department of Oncology

No. 76 Jiefang Avenue
Wuhan, 430030
China

Bin Yan

Huazhong University of Science and Technology (Formerly Tongi Medical University)

1037 Luoyu Rd
Wuhan, Hubei 430074
China

Hong-Lin Jin

Huazhong University of Science and Technology (Formerly Tongi Medical University) - Cancer Center

China

Li Su

Huazhong University of Science and Technology (Formerly Tongi Medical University)

1037 Luoyu Rd
Wuhan, Hubei 430074
China

Jun Weng

Huazhong University of Science and Technology (Formerly Tongi Medical University)

1037 Luoyu Rd
Wuhan, Hubei 430074
China

Xiang-Lin Yuan

Huazhong University of Science and Technology (Formerly Tongi Medical University)

1037 Luoyu Rd
Wuhan, Hubei 430074
China

Dong-Xin Zhang

Huazhong University of Science and Technology (Formerly Tongi Medical University) - Department of Clinical Laboratory ( email )

No. 76 Jiefang Avenue
Wuhan, 430030
China

Jueping Feng (Contact Author)

Huazhong University of Science and Technology (Formerly Tongi Medical University) - Department of Oncology ( email )

No. 76 Jiefang Avenue
Wuhan, 430030
China

Click here to go to TheLancet.com

Go to TheLancet.com

Paper statistics

Abstract Views
162
Downloads
36